April 22, 2026 Expanding Access to GLP-1s in Medicare and Medicaid: CMS Initiatives, the BALANCE Model, and Implications for Beneficiaries and Budgets
March 31, 2026 Project Remission: New Film Series Highlights Lifestyle Medicine for Type 2 Diabetes Reversal
February 25, 2026 Novo Nordisk’s UBT251: Promising New Weight Loss Drug Shows 20% Weight Loss in Trial
_1b78fec41a5143afb6e7b9ad317023d2-620x480.jpg)
